2014
DOI: 10.1016/j.ejmech.2013.10.014
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of a new class of pyrrolo[3,4-h]quinazolines with antimitotic activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
24
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 47 publications
(24 citation statements)
references
References 38 publications
0
24
0
Order By: Relevance
“…In the framework of our research on polycyclic nitrogen systems, [16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33] particularly referring to nortopsentin alkaloid analogues [34,35,36,37,38,39], herein we report the synthesis of the new series of thiazoles 1 (Table 1) and their evaluation as antibiofilm agents. In this series of nortopsentin analogues, the imidazole core of the natural product is replaced by the thiazole ring and one of the indole units is replaced by a 7-aza-indole moiety decorated with an ethanamine chain bound to the imine nitrogen.…”
Section: Introductionmentioning
confidence: 99%
“…In the framework of our research on polycyclic nitrogen systems, [16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33] particularly referring to nortopsentin alkaloid analogues [34,35,36,37,38,39], herein we report the synthesis of the new series of thiazoles 1 (Table 1) and their evaluation as antibiofilm agents. In this series of nortopsentin analogues, the imidazole core of the natural product is replaced by the thiazole ring and one of the indole units is replaced by a 7-aza-indole moiety decorated with an ethanamine chain bound to the imine nitrogen.…”
Section: Introductionmentioning
confidence: 99%
“…Anticancer agent Iressa (ZD1839) A is a clinically approved example of quinazoline-based inhibitors which is in phase III clinical trials for cancer used to inhibit the receptor tyrosine kinase of epidermal growth factor. also exhibit pronounced biological activities as antimicrobial, 7,8 anti-HIV (NNRTI), 9,10 anti-tumour, [11][12][13][14][15][16] potential analgesic and anti-inflammatory activity. 17 Non-proteinogenic amino acids are major component in a number of drugs including β-lactam antibiotics 18 and glutamate antagonists.…”
Section: Introductionmentioning
confidence: 99%
“…Among various heterocyclic compounds, N ‐heterocyclic compounds are very important in drug design . Compounds containing pyrrolopyrimidine functional groups, collectively referred to as 7‐deazapurines, are a structurally diverse class of nucleoside analogs with demonstrated antibiotic .…”
Section: Introductionmentioning
confidence: 99%